Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic Acid Dimethyl Ester
2. Alpha-diphenyldicarboxylate
3. Bdd
4. Biphenyl Dimethyl-dicarboxylate
5. Dimethyl 4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate
6. Dimethyl Diphenyl Bicarboxylate
7. Diphenyl Dimethyl Dicarboxylate
1. 73536-69-3
2. Bifendatatum
3. Dimethyl 7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5,5'-dicarboxylate
4. .alpha.-ddb
5. Bifendate,(s)
6. Methyl 7-methoxy-4-(7-methoxy-5-methoxycarbonyl-1,3-benzodioxol-4-yl)-1,3-benzodioxole-5-carboxylate
7. 7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic Acid Dimethyl Ester
8. Dimethyl Dicarboxylate Biphenyl
9. Diphenyl Dimethyl Bicarboxylate
10. Mfcd01751431
11. 0g32e321w1
12. Alpha-diphenyldicarboxylate
13. Biphenyl Dimethyl-dicarboxylate
14. Diphenyl Dimethyl Dicarboxylate
15. Ccris 7767
16. Brn 5461320
17. Dimethyl Diphenyl Bicarboxylate
18. Unii-0g32e321w1
19. Dimethyl 7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylate
20. Dimethyl-4,4'-dimethoxyl-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate
21. Bifendate [who-dd]
22. Dimethyl 4,4'-dimethoxy-5,6,5',6'-bis(methylenedioxy)biphenyl-2,2'-dicarboxylate
23. Schembl896166
24. Chembl105184
25. Dtxsid40223736
26. Bcp12613
27. Bdbm50289527
28. S4890
29. Zinc12153845
30. Akos015895317
31. Ccg-268865
32. Cs-w019577
33. Hy-w018791
34. Sb67338
35. (4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic Acid, 7,7'-dimethoxy-, Dimethyl Ester
36. As-13115
37. Sy021274
38. B6112
39. Ft-0602821
40. 536b693
41. A866077
42. Q27236735
43. 2,2'-dimethoxycarbonyl-4,4'-dimethoxy-5,6,5',6'-bismethylenedioxybiphenyl
44. Dimethyl 7,7'-dimethoxy-4,4'-bibenzo[d][1,3]dioxole-5,5'-dicarboxylate
45. Dimethyl7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5,5'-dicarboxylate
46. [4,4'-bi-1,3-benzodioxole]-5,5'-dicarboxylic Acid, 7,7'-dimethoxy-,dimethyl Ester
47. Dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate
48. (4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic Acid, 7,7'-dimethoxy-, 5,5'-dimethyl Ester
49. Dimethyl 7,7 Inverted Exclamation Mark -dimethoxy-[4,4 Inverted Exclamation Mark -bi-1,3-benzodioxole]-5,5 Inverted Exclamation Mark -dicarboxylate
Molecular Weight | 418.3 g/mol |
---|---|
Molecular Formula | C20H18O10 |
XLogP3 | 2.8 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 7 |
Exact Mass | 418.08999677 g/mol |
Monoisotopic Mass | 418.08999677 g/mol |
Topological Polar Surface Area | 108 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 587 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Adjuvants, Immunologic
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Cytochrome P-450 Enzyme Inhibitors
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES. (See all compounds classified as Cytochrome P-450 Enzyme Inhibitors.)
Bifendate has known human metabolites that include Mono-O-demethylated bdd and methyl 4-(2,3-dihydroxy-4-methoxy-6-methoxycarbonylphenyl)-7-methoxy-1,3-benzodioxole-5-carboxylate.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
About the Company : Jinzhou Jiutai Pharmaceutical is a comprehensive pharmaceutical enterprise which has more than 60 years manufacturing history. It was set up in 1951. There are 5 workshops, one res...
About the Company : Zhejiang Hisoar Pharmaceutical Co., Ltd. is located in Taizhou, Zhejiang. It is an IPO-listed company held by the DanKong Group, which mainly manufactures APIs, Formulations, Fine ...
Market Place
Reply
28 Feb 2022
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?